Who Paid My Doc
Benjamin Winston
Reno, NV Medical Doctor
NPI 1740523265 CMS profile 4564130
555 N Arlington Ave, Reno, NV 89503
General payments
$11,999
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Benjamin Winston of Reno, NV is reported in the CMS Open Payments database as having received $11,999 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $11,999 | 7 |
Beside peers
- Benjamin Winston
- Nevada median
- Middle half of Nevada
- National median
In program year 2025, general payments to Benjamin Winston were reported at $0. Among 8,799 Nevada profiles paid that year, the median was $206 and the middle half received between $66 and $705.
Show as a table
| Year | Benjamin Winston | Nevada median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $11,999 | $204 | $61–$837 | $163 |
| 2020 | $0 | $130 | $40–$438 | $114 |
| 2021 | $0 | $175 | $50–$617 | $132 |
| 2022 | $0 | $173 | $52–$609 | $149 |
| 2023 | $0 | $194 | $66–$644 | $160 |
| 2024 | $0 | $196 | $61–$687 | $164 |
| 2025 | $0 | $206 | $66–$705 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
70
Drug cost
$640
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 54 | $511 | |
| Meloxicam | Generic | 16 | $129 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.